Your browser doesn't support javascript.
loading
Human Wharton's Jelly-derived mesenchymal stem cells prevent acetaminophen-induced liver injury in a mouse model unlike human dermal fibroblasts.
Umbaugh, David S; Soder, Rupal P; Nguyen, Nga T; Adelusi, Olamide; Robarts, Dakota R; Woolbright, Ben; Duan, Luqi; Abhyankar, Sunil; Dawn, Buddhadeb; Apte, Udayan; Jaeschke, Hartmut; Ramachandran, Anup.
Afiliação
  • Umbaugh DS; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1018, Kansas City, KS, 66160, USA.
  • Soder RP; Midwest Stem Cell Therapy Center, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1075, Kansas City, KS, 66160, USA.
  • Nguyen NT; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1018, Kansas City, KS, 66160, USA.
  • Adelusi O; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1018, Kansas City, KS, 66160, USA.
  • Robarts DR; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1018, Kansas City, KS, 66160, USA.
  • Woolbright B; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1018, Kansas City, KS, 66160, USA.
  • Duan L; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1018, Kansas City, KS, 66160, USA.
  • Abhyankar S; Midwest Stem Cell Therapy Center, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1075, Kansas City, KS, 66160, USA.
  • Dawn B; Blood and Marrow Transplant Program, Division of Hematologic Malignancies and Cellular Therapeutics Center, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1018, Kansas City, KS, 66160, USA.
  • Apte U; Midwest Stem Cell Therapy Center, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1075, Kansas City, KS, 66160, USA.
  • Jaeschke H; Department of Internal Medicine, Kirk Kerkorian School of Medicine at the University of Nevada, Las Vegas, USA.
  • Ramachandran A; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1018, Kansas City, KS, 66160, USA.
Arch Toxicol ; 96(12): 3315-3329, 2022 12.
Article em En | MEDLINE | ID: mdl-36057886
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Doença Hepática Induzida por Substâncias e Drogas / Doença Hepática Crônica Induzida por Substâncias e Drogas / Geleia de Wharton / Células-Tronco Mesenquimais Tipo de estudo: Etiology_studies Limite: Animals / Humans Idioma: En Revista: Arch Toxicol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Doença Hepática Induzida por Substâncias e Drogas / Doença Hepática Crônica Induzida por Substâncias e Drogas / Geleia de Wharton / Células-Tronco Mesenquimais Tipo de estudo: Etiology_studies Limite: Animals / Humans Idioma: En Revista: Arch Toxicol Ano de publicação: 2022 Tipo de documento: Article